Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...

It is predicted that the first new drug developed by artificial intelligence (AI) may be commercialized in 2030. Alex ...

Keros Therapeutics Inc (NASDAQ:KROS) released topline data from the TROPOS Phase 2 trial of cibotercept (KER-012) in ...

Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

It is not surprising that President Trump issued a May 12, 2025 executive order, “Delivering Most-Favored-Nation Prescription ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.